Thomas Graham, Alan, Irving Kahns
Kahn Brothers Group
Kahn Brothers Group Portfolio 13F
Kahn Brothers Group Holdings Activity
- Portfolio value:
- $687.29M≈ (+$39M≈)
- Previous value:
- $648.04M≈
- # of changes:
- 35
- New positions:
- 2
- Reported for:
- 30 Sep 2013 (Q3)
- Latest filing date:
- 06 Nov 2013
Kahn Brothers Group has disclosed a total of 35 changes to the portfolio in the (2013 Q3) SEC report(s): increased the number of shares of 12, bought 2 totally new, decreased the number of shares of 16 and completely sold out 5 position(s).
What stocks did Kahn Brothers Group buy in 2013 Q3?
During 2013 Q3 Kahn Brothers Group has bought 14 securities out of which top 5 purchases (by % change to portfolio) were (NYT) New York Times Company (added shares +1.00%), (C) Citigroup Inc (added shares +1.09%), (FLG) Flagstar Financial, Inc (added shares +3.52%), (MRK) Merck & Company Inc (added shares +1.06%) and (ORI) Old Republic International Corp (added shares +0.36%).
In the 2013 Q3 report(s) the following changes have been made to the top investments: (PFE) Pfizer Inc (reduced shares -1.32%), (NYT) New York Times Company (added shares +1.00%), (C) Citigroup Inc (added shares +1.09%), (FLG) Flagstar Financial, Inc (added shares +3.52%) and (MRK) Merck & Company Inc (added shares +1.06%).
35 results
| History | Ticker | Name |
% or activity |
Shares change |
Shares held after* |
% change to portfolio |
Reported price* |
% difference current price* |
% of portfolio |
Held since* | Held for* |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
BlackBerry Ltd
|
new
|
$7.95
|
+11.89%($8.90)
|
0.45%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
Straight Path Communications Inc
|
new
|
$5.26
|
|
0.26%
|
2013 Q3
|
≈ 0.25 years
|
||||
|
|
BP PLC-SPONS ADR
|
+539.55%
|
$42.03
|
-1.06%($41.58)
|
2.99%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
|
|
Flagstar Financial, Inc
|
+3.52%
|
$15.11
|
-4.93%($14.36)
|
9.12%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
|
|
Patterson-UTI Energy Inc
|
+1.58%
|
$21.38
|
-54.47%($9.74)
|
6.13%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
|
|
Citigroup Inc
|
+1.09%
|
$48.51
|
+185.76%($138.62)
|
9.70%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
|
|
Merck & Company Inc
|
+1.06%
|
$47.61
|
+171.09%($129.06)
|
8.51%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
|
|
New York Times Company
|
+1.00%
|
$12.57
|
+403.86%($63.34)
|
9.95%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
|
|
MBIA Inc
|
+0.59%
|
$10.23
|
-48.34%($5.28)
|
4.44%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
|
|
Hologic Inc
|
+0.51%
|
$20.65
|
|
4.66%
|
2013 Q2 or earlier
|
≈ 0.50+ years
|
||||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
* Current price: this can be a delayed price and may not reflect the real-time market value, however it is too close.
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* Held since / Held for: calculated since the latest "new buy" position. If the security was previously exited and re-entered, only the most recent holding period is counted.